Sinopharm Tech Holdings Balance Sheet Health
Financial Health criteria checks 0/6
Sinopharm Tech Holdings has a total shareholder equity of HK$-182.5M and total debt of HK$10.0M, which brings its debt-to-equity ratio to -5.5%. Its total assets and total liabilities are HK$46.2M and HK$228.7M respectively.
Key information
-5.5%
Debt to equity ratio
HK$10.00m
Debt
| Interest coverage ratio | n/a |
| Cash | HK$8.51m |
| Equity | -HK$182.51m |
| Total liabilities | HK$228.74m |
| Total assets | HK$46.23m |
Recent financial health updates
No updates
Recent updates
Is Sinopharm Tech Holdings Limited's (HKG:8156) Shareholder Ownership Skewed Towards Insiders?
Feb 02
How Much Did Sinopharm Tech Holdings'(HKG:8156) Shareholders Earn From Share Price Movements Over The Last Five Years?
Dec 29
How Should Investors Feel About Sinopharm Tech Holdings' (HKG:8156) CEO Remuneration?
Nov 24Financial Position Analysis
Short Term Liabilities: 8156 has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: 8156 has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: 8156 has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: 8156's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 8156 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 8156 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.